Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-018436
Filing Date
2020-07-24
Accepted
2020-07-24 06:01:09
Documents
2
Period of Report
2020-07-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea124505-6k_tiziana.htm 6-K 13817
2 REGULATORY NEWS SERVICE ANNOUNCEMENT, DATED JULY 24, 2020 ea124505ex99-1_tiziana.htm EX-99.1 8213
  Complete submission text file 0001213900-20-018436.txt   23063
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 201044972
SIC: 2834 Pharmaceutical Preparations